Published in Vaccine Weekly, May 16th, 2007
"Dual-specific T cells were generated by gene modification of influenza virus-specific mouse T cells with a...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
Source: Vaccine Weekly (2007-05-16)
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.